High glucose induces plasminogen activator inhibitor-1 expression through Rho/Rho-kinase-mediated NF-κB activation in bovine aortic endothelial cells

2007/02/03 by Hitoshi Iwasaki, Ryuji Okamoto, Shinya Kato +6 · 12 citations
Biochemistry, Genetics and Molecular Biology · #Protease and Inhibitor Mechanisms #Calpain Protease Function and Regulation #NF-κB Signaling Pathways

paper · doi:10.1016/j.atherosclerosis.2006.12.025

Cited by

• Rho kinase: an important mediator of atherosclerosis and vascular disease. [europepmc]
• Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. [europepmc]
• High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels. [europepmc]
• Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism. [europepmc]
• Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. [europepmc]
• Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells. [europepmc]
• Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal. [europepmc]
• Dysregulation of 2-oxoglutarate-dependent dioxygenases by hyperglycaemia: does this link diabetes and vascular disease? [europepmc]
• A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? [europepmc]
• Blood PAI-1 and cardiovascular and metabolic risk factors among the middle-aged women from SWAN study. [europepmc]
• Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers. [europepmc]
• Stress hyperglycemia ratio and machine learning model for prediction of all-cause mortality in critically ill patients with acute kidney injury: A cohort study from MIMIC-IV. [europepmc]